# Validation of a New Innovative Method for Specific Marker Detection in Celiac Disease

> **NCT06324539** · — · RECRUITING · sponsor: **IRCCS Burlo Garofolo** · enrollment: 332 (estimated)

## Conditions studied

- Celiac Disease in Children

## Interventions

- **DIAGNOSTIC_TEST:** Diagnostic Test: Rapid Intestinal anti-TG2 Assay
- **DIAGNOSTIC_TEST:** Diagnostic Test: Rapid Intestinal anti-TG2 Assay

## Key facts

- **NCT ID:** NCT06324539
- **Lead sponsor:** IRCCS Burlo Garofolo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-04
- **Primary completion:** 2025-05
- **Final completion:** 2025-05
- **Target enrollment:** 332 (ESTIMATED)
- **Last updated:** 2024-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06324539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06324539, "Validation of a New Innovative Method for Specific Marker Detection in Celiac Disease". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT06324539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*